House Democrat places hold on Trump's $2.8 billion bomb sale to Israel

The top Democrat on the House Foreign Affairs Committee has refused to sign off on a proposed $2.8 billion sale of heavy bombs to Israel, an unusual public break that stalls one of the largest single munitions packages the Trump administration has sought to send the Netanyahu government since the war in Gaza began. Representative Gregory Meeks of New York, ranking member of the committee, said Wednesday he would not clear the transfer "at this time," citing what he called unresolved questions about how the munitions would be used in populated areas.

Meeks's objection came as the State Department was informally notifying relevant congressional committees of the proposed sale, a required early step in a review process that gives lawmakers a confidential window to object before any formal transfer is announced. His office said in a statement released by the committee's Democratic staff that the administration "has not provided sufficient assurances that these weapons will be used by the Netanyahu government in accordance with U.S. law and with appropriate protections for civilians."

The numbers

The package under review is valued at $2.8 billion and centers on 40,000 bombs in the 2,000-pound class, among the most destructive conventional munitions in the U.S. arsenal. According to reporting on the package's composition, cited by Al Jazeera, it includes 20,000 MK-84 general-purpose bombs and 20,000 BLU-117 bombs, a variant built with extra thermal protection for shipboard storage, along with I-2000 Penetrator warheads designed to fit bunker-busting versions of the weapon. Most of the sale would be paid for through the Foreign Military Financing program, meaning the bulk of the cost falls to American taxpayers rather than the Israeli government directly. Under the Arms Export Control Act, Israel is one of a small group of allies, along with NATO members, Japan, Australia, South Korea and New Zealand, that receive an expedited 15-day formal congressional review window once a sale is formally notified, half the 30 days required for most other buyers, according to a State Department summary of the process. This sale has not yet reached that formal stage.

How the review works

Before any arms sale is formally announced, the State Department typically gives the House Foreign Affairs Committee and the Senate Foreign Relations Committee an informal notification, usually 20 to 40 days ahead of formal notice, so that the chair and ranking member of each panel can raise objections in private. The department "generally will not formally notify an arms transfer if a member of Congress raises significant concerns by placing a hold during the informal review stage," though it is not legally barred from doing so, according to the Congressional Research Service's account of the statute. That informal, member-level hold is what Meeks has now placed. It is a norm rather than a binding veto: the executive branch retains the authority to proceed to formal notification over a lawmaker's objection, and Congress can only stop a sale outright by passing a joint resolution of disapproval, which would require overcoming a presidential veto. The Trump administration has previously used emergency authority under the same law to bypass the review period entirely, doing so twice in one month earlier this year for separate arms packages to Israel that together totaled roughly $3 billion.

Who is affected

The dispute lands squarely on the war-battered populations of Gaza and southern Lebanon, where 2,000-pound bombs of the kind at issue have previously been used in strikes on buildings and tunnel networks in dense urban settings. It also touches the Israeli military, which has sought steady resupply of heavy ordnance since the war began in October 2023, and American defense contractors that manufacture the munitions. Politically, it exposes a familiar rift inside the Democratic Party between lawmakers such as Meeks, a longtime supporter of Israel who chaired the Foreign Affairs Committee as recently as 2023, and a growing bloc of members demanding stricter conditions on military aid over civilian casualties. The Biden administration paused a shipment of similar 2,000-pound bombs in 2024 out of concern about their use in a planned Israeli offensive in Rafah; President Trump lifted that pause after taking office in January 2025.

Reaction

"The Trump administration's proposed sale of 40,000 2,000-pound bombs, some of the most destructive munitions in our arsenal, raises grave, unresolved concerns about how these munitions could be used in densely populated areas of Gaza and Lebanon."

That was Meeks's core objection, paired with a statement that he "remains firmly committed to Israel's security and its ability to defend itself against serious regional threats." Senator Chris Van Hollen of Maryland, a member of the Senate Foreign Relations Committee, said Wednesday he would work to block the sale as well, framing it in blunter terms as, in his words reported by Jewish Insider, sending "$2.8 billion of bombs paid for by you, the American taxpayer, to a government led by a wanted war criminal," a reference to the International Criminal Court's 2024 arrest warrant for Israeli Prime Minister Benjamin Netanyahu. The State Department has said it does not comment on proposed sales before they are formally notified to Congress. Neither the Israeli government nor its embassy in Washington issued a public response to Meeks's hold. The Jewish Telegraphic Agency noted that Meeks, despite his long record of support for Israel, has grown increasingly critical of the Netanyahu government's conduct of the war and previously moved to block a separate F-15 fighter jet sale in 2024.

What happens next

Meeks's hold does not kill the sale. It freezes the package at the informal-review stage, where it is likely to remain unless the administration either satisfies his committee's questions about end-use assurances or decides to push forward anyway. Because Republicans control both chambers, a joint resolution of disapproval of the kind Van Hollen and other senators have discussed would face long odds even if it reached the floor, and would still need to survive a presidential veto. The more immediate question is whether the White House chooses to wait Meeks out, offer written assurances on how the bombs would be used, or invoke emergency authority to bypass the review altogether, as it did with prior Israel arms packages. For now, the administration has not said publicly which path it will take, and the $2.8 billion package remains on hold at the committee level rather than headed toward formal notification.